RAPT Therapeutics, Inc. (RAPT)

RAPT Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.26	169.74	47.48	38.95	24.03	24.92
Short-Term Investments	119.02	61.32	111.38	210.12	165.63	86.59
Cash & Short-Term Investments	179.28	231.06	158.86	249.07	189.65	111.51
Cash Growth	26.63%	45.44%	-36.22%	31.33%	70.08%	44.10%
Prepaid Expenses	3.92	4.18	2.92	3.63	3.32	4.09
Total Current Assets	183.2	235.24	161.78	252.69	192.97	115.6
Property, Plant & Equipment	3.99	4.7	7.68	9.48	2.74	2.98
Other Long-Term Assets	0.39	0.39	3.87	4.04	2.92	0.39
Total Assets	187.57	240.33	173.33	266.21	198.64	118.97
Accounts Payable	1.3	1.28	5.18	3.37	2	2.38
Accrued Expenses	4.93	44.6	14.1	8.66	6.33	4.94
Current Portion of Leases	2.32	2.42	2.45	2.17	-	-
Current Unearned Revenue	-	-	-	-	1.02	4.1
Other Current Liabilities	0.14	0.06	0.11	0.03	0.25	0.33
Total Current Liabilities	8.68	48.35	21.84	14.22	9.6	11.74
Long-Term Leases	1.52	2.07	4.46	6.82	-	-
Long-Term Unearned Revenue	-	-	-	-	0.51	0.86
Other Long-Term Liabilities	-	-	-	-	2.15	2.19
Total Liabilities	10.2	50.42	26.29	21.04	12.26	14.79
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	809.04	804.39	631.61	613.07	470.63	319.2
Retained Earnings	-631.71	-614.55	-484.68	-367.88	-284.05	-214.84
Comprehensive Income & Other	0.04	0.05	0.1	-0.03	-0.21	-0.18
Total Common Equity	177.37	189.9	147.04	245.17	186.38	104.18
Shareholders' Equity	177.37	189.9	147.04	245.17	186.38	104.18
Total Liabilities & Equity	187.57	240.33	173.33	266.21	198.64	118.97
Total Debt	3.84	4.49	6.91	8.99	-	-
Net Cash (Debt)	175.44	226.56	151.96	240.08	189.65	111.51
Net Cash Growth	29.71%	49.10%	-36.71%	26.59%	70.08%	44.10%
Net Cash Per Share	16.52	44.47	31.71	59.02	55.39	36.96
Filing Date Shares Outstanding	16.54	16.5	4.35	4.29	3.7	3.11
Total Common Shares Outstanding	16.5	16.5	4.3	4.28	3.69	3.1
Working Capital	174.52	186.89	139.95	238.47	183.38	103.86
Book Value Per Share	10.75	11.51	34.20	57.26	50.45	33.64
Tangible Book Value	177.37	189.9	147.04	245.17	186.38	104.18
Tangible Book Value Per Share	10.75	11.51	34.20	57.26	50.45	33.64
Machinery	8.17	8.15	8.52	7.49	7.13	6.77
Leasehold Improvements	3.3	3.3	3.3	3.3	3.3	3.29

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q